Literature DB >> 28002390

Therapeutic hypothermia modulates complement factor C3a and C5a levels in a rat model of hypoxic ischemic encephalopathy.

Tushar A Shah1,2,3,4, Jasmine E Nejad1, Haree K Pallera1, Frank A Lattanzio1, Rawad Farhat1, Parvathi S Kumar1, Pamela S Hair1, W Thomas Bass1,3,4, Neel K Krishna1,2.   

Abstract

BACKGROUND: Therapeutic hypothermia (HT) is the only intervention that improves outcomes in neonatal hypoxic-ischemic encephalopathy (HIE). However, the multifactorial mechanisms by which HT impacts HIE are incompletely understood. The complement system plays a major role in the pathogenesis of ischemia-reperfusion injuries such as HIE. We have previously demonstrated that HT modulates complement activity in vitro.
METHODS: Term equivalent rat pups were subjected to unilateral carotid ligation followed by hypoxia (8% O2) for 45 min to simulate HIE. A subset of animals was subjected to HT (31-32°C for 6 h). Plasma and brain levels of C3a and C5a were measured. Receptors for C3a (C3aR) and C5a (C5aR) along with C1q, C3, and C9 were characterized in neurons, astrocytes, and microglia.
RESULTS: We found that HT increased systemic expression of C3a and decreased expression of C5a after HIE. In the brain, C3aR and C5aR are predominantly expressed on microglia after HIE. HT increased local expression of C3aR and decreased expression on C5aR after HIE. Furthermore, HT decreased local expression of C1q, C3-products, and C9 in the brain.
CONCLUSION: HT is associated with significant alteration of complement effectors and their cognate receptors. Complement modulation may improve outcomes in neonatal HIE.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28002390     DOI: 10.1038/pr.2016.271

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  40 in total

1.  The C5a complement activation peptide increases IL-1beta and IL-6 release from amyloid-beta primed human monocytes: implications for Alzheimer's disease.

Authors:  S O'Barr; N R Cooper
Journal:  J Neuroimmunol       Date:  2000-09-22       Impact factor: 3.478

Review 2.  Ischaemia-reperfusion is an event triggered by immune complexes and complement.

Authors:  R K Chan; S I Ibrahim; N Verna; M Carroll; F D Moore; H B Hechtman
Journal:  Br J Surg       Date:  2003-12       Impact factor: 6.939

Review 3.  Complement and the central nervous system: emerging roles in development, protection and regeneration.

Authors:  Martin J Rutkowski; Michael E Sughrue; Ari J Kane; Steven A Mills; Shanna Fang; Andrew T Parsa
Journal:  Immunol Cell Biol       Date:  2010-04-20       Impact factor: 5.126

Review 4.  Complement and its role in innate and adaptive immune responses.

Authors:  Jason R Dunkelberger; Wen-Chao Song
Journal:  Cell Res       Date:  2009-12-15       Impact factor: 25.617

Review 5.  Complement mediators in ischemia-reperfusion injury.

Authors:  Thiruma V Arumugam; Tim Magnus; Trent M Woodruff; Lavinia M Proctor; Ian A Shiels; Stephen M Taylor
Journal:  Clin Chim Acta       Date:  2006-06-14       Impact factor: 3.786

6.  Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease.

Authors:  Rahasson R Ager; Maria I Fonseca; Shu-Hui Chu; Sam D Sanderson; Stephen M Taylor; Trent M Woodruff; Andrea J Tenner
Journal:  J Neurochem       Date:  2010-02-02       Impact factor: 5.372

7.  The role of complement in neurodevelopmental impairment following neonatal hypoxic-ischemic encephalopathy.

Authors:  Hany Aly; Mohamed T Khashaba; Ayman Nada; Bothina M Hasanen; Robert McCarter; Seth J Schultz; Laura Gordon; Pamela W Feldhoff; Herbert A Lassiter
Journal:  Am J Perinatol       Date:  2009-04-23       Impact factor: 1.862

Review 8.  Perinatal hypoxic-ischemic encephalopathy.

Authors:  Ming-Chi Lai; San-Nan Yang
Journal:  J Biomed Biotechnol       Date:  2010-12-13

Review 9.  Antimicrobial peptides and complement in neonatal hypoxia-ischemia induced brain damage.

Authors:  Eridan Rocha-Ferreira; Mariya Hristova
Journal:  Front Immunol       Date:  2015-02-12       Impact factor: 7.561

10.  Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway.

Authors:  Tushar A Shah; Clifford T Mauriello; Pamela S Hair; Amandeep Sandhu; Michael P Stolz; William Thomas Bass; Neel K Krishna; Kenji M Cunnion
Journal:  J Transl Med       Date:  2014-06-24       Impact factor: 5.531

View more
  10 in total

1.  Mild Hypothermia Alleviates Complement C5a-Induced Neuronal Autophagy During Brain Ischemia-Reperfusion Injury After Cardiac Arrest.

Authors:  Ling Wang; Yuanyuan Sun; Fang Kong; Yi Jiang; Mengmeng An; Beibei Jin; Da Cao; Ruifang Li; Xiaolan Guan; Shuangshuang Liang; Subi Abudurexiti; Ping Gong
Journal:  Cell Mol Neurobiol       Date:  2022-08-25       Impact factor: 4.231

2.  Translational Block in Stroke: A Constructive and "Out-of-the-Box" Reappraisal.

Authors:  Athanasios Lourbopoulos; Iordanis Mourouzis; Christodoulos Xinaris; Nefeli Zerva; Konstantinos Filippakis; Angelos Pavlopoulos; Constantinos Pantos
Journal:  Front Neurosci       Date:  2021-05-14       Impact factor: 4.677

Review 3.  Aberrant Complement System Activation in Neurological Disorders.

Authors:  Karolina Ziabska; Malgorzata Ziemka-Nalecz; Paulina Pawelec; Joanna Sypecka; Teresa Zalewska
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

4.  Identification of novel biomarkers for neonatal hypoxic-ischemic encephalopathy using iTRAQ.

Authors:  Yuanyuan Zhu; Yajing Yun; Meifang Jin; Gen Li; Hong Li; Po Miao; Xin Ding; Xing Feng; Lixiao Xu; Bin Sun
Journal:  Ital J Pediatr       Date:  2020-05-24       Impact factor: 2.638

5.  Therapeutic Hypothermia Inhibits the Classical Complement Pathway in a Rat Model of Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Tushar A Shah; Haree K Pallera; Cortney L Kaszowski; William Thomas Bass; Frank A Lattanzio
Journal:  Front Neurosci       Date:  2021-02-12       Impact factor: 4.677

6.  C3a Receptor Signaling Inhibits Neurodegeneration Induced by Neonatal Hypoxic-Ischemic Brain Injury.

Authors:  Andrea Pozo-Rodrigálvarez; YiXian Li; Anna Stokowska; Jingyun Wu; Verena Dehm; Hana Sourkova; Harry Steinbusch; Carina Mallard; Henrik Hagberg; Milos Pekny; Marcela Pekna
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

Review 7.  Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury.

Authors:  Marcela Pekna; Anna Stokowska; Milos Pekny
Journal:  Neurochem Res       Date:  2021-08-11       Impact factor: 3.996

Review 8.  The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides, Additional Mechanisms of Action, and In Vivo and Ex Vivo Efficacy.

Authors:  Neel K Krishna; Kenji M Cunnion; Grace A Parker
Journal:  Front Immunol       Date:  2022-02-09       Impact factor: 7.561

9.  Ambient Temperature Is Correlated With the Severity of Neonatal Hypoxic-Ischemic Brain Injury via Microglial Accumulation in Mice.

Authors:  Rika Zen; Tomoya Terashima; Shunichiro Tsuji; Miwako Katagi; Natsuko Ohashi; Yuri Nobuta; Asuka Higuchi; Hirohiko Kanai; Takashi Murakami; Hideto Kojima
Journal:  Front Pediatr       Date:  2022-05-06       Impact factor: 3.418

10.  Early Detection of Hypothermic Neuroprotection Using T2-Weighted Magnetic Resonance Imaging in a Mouse Model of Hypoxic Ischemic Encephalopathy.

Authors:  Sydney E Doman; Akanksha Girish; Christina L Nemeth; Gabrielle T Drummond; Patrice Carr; Maxine S Garcia; Michael V Johnston; Sujatha Kannan; Ali Fatemi; Jiangyang Zhang; Mary Ann Wilson
Journal:  Front Neurol       Date:  2018-05-08       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.